The 20 Best Trophoblastic Tumor Placental Site Doctors Near Me in Maryland, US

Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies. Dr. Gaillard is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Tissue Biopsy, and Salpingo-Oophorectomy. Dr. Gaillard is board certified in American Board Of Internal Medicine.

Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy. Dr. Yarchoan is board certified in American Board Of Internal Medicine.

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy. Dr. Azad is board certified in American Board Of Internal Medicine.

Dr. Webster is an Assistant Professor of Oncology at The Johns Hopkins University School of Medicine. He is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Webster has expertise in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and myelodysplastic syndrome (MDS). Dr. Webster received his medical degree from The Stanford University School of Medicine. He completed residency training in internal medicine at Johns Hopkins followed by a fellowship in medical oncology. He completed the Science of Clinical Investigation curriculum at the Johns Hopkins Bloomberg School of Public health. Dr. Webster is a member of the American Society of Hematology, and the American Society of Clinical Oncology. Dr. Webster’s research activities consist of designing and conducting clinical trials that test investigational new therapies and approaches in the treatment of acute leukemias (ALL and AML). He has specific expertise in the use of maintenance therapies following bone marrow transplantation. He has developed novel clinical trials utilizing immunotherapy for the treatment of ALL and the prevention of post-transplant relapse in both ALL and AML. He serves as the Principal Investigator for these trials of post-transplant maintenance strategies, as well as the site PI for multi-center trials that are currently being conducted through the Eastern Co-operative Oncology Group (ECOG)-ACRIN and Experimental Therapeutics Clinical Trials Network (ETCTN). As the leader of the adult ALL program at Johns Hopkins, he has focused on increasing clinical trial enrollments and improving outcomes in adult ALL. Dr. Webster is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Leukemia, and Bone Marrow Aspiration.

Dr. Angie Jelin is the assistant director of prenatal genetics at the Prenatal Diagnostic Center in the Division of Maternal-Fetal Medicine and an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her areas of clinical expertise include prenatal genetic counseling, fetal imaging, chorionic villus sampling and amniocentesis, with a focus on fetal complications in pregnancy. Dr. Jelin earned her medical degree from Harvard Medical School. She did her residency in obstetrics and gynecology at the University of California, San Francisco, and then remained there to complete a maternal-fetal medicine and genetics fellowship. In 2015, Dr. Jelin joined the Johns Hopkins faculty, at which time she also received a Building Interdisciplinary Research Careers in Women’s Health grant to study fetal genetic disorders. Dr. Jelin’s research involves fetal imaging and genetic diagnoses, including whole exome sequencing. Dr. Jelin is a member of the American College of Obstetricians and Gynecologists, the Society of Maternal-Fetal Medicine and the International Society of Prenatal Diagnosis. She currently serves on the IRB committee of the American Board of Obstetrics and Gynecology. Dr. Jelin has published many articles in obstetrics and maternal-fetal medicine journals. Dr. Jelin is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Polyhydramnios, Bilateral Renal Agenesis Dominant Type, Lung Agenesis, and Atresia of Small Intestine. Dr. Jelin is board certified in American Board Of Medical Genetics And Genomics and American Board Of Obstetrics And Gynecology.

Dr. Rebecca Stone is an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her area of clinical expertise is gynecologic cancers, including cervical, uterine, vulvar and ovarian cancer, as well as gestational trophoblastic disease. Dr. Stone is a highly skilled surgeon with expertise in laparoscopic and robotic surgery for gynecologic tumors. She also serves as director of the Gynecology Enhanced Recovery after Surgery initiative, an innovative, multidisciplinary program that improves recovery and healing time after major abdominal surgery, as well as minimizes health care costs for patients. Dr. Stone received her undergraduate degree in biology from the University of Virginia. She earned her medical degree from the University of Virginia School of Medicine, where she subsequently completed her residency in obstetrics and gynecology. Dr. Stone performed a four-year gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center. She also earned a master’s degree in cancer biology from the University of Texas in 2010. Prior to joining Johns Hopkins, Dr. Stone was an assistant professor at the University of Arkansas for Medical Sciences, where she was one of five gynecologic oncologists serving the entire state. Dr. Stone is internationally recognized for her research pertaining to early diagnosis and treatment of ovarian cancer. She is widely published in the field of gynecologic oncology, with first-author papers in the New England Journal of Medicine and Lancet Oncology, as well as over 40 co-authored manuscripts in peer-reviewed medical journals. She was honored with an award for one of the most influential papers published in the field of obstetrics and gynecology in 2012 and with an Ovarian Cancer Research Fund Grant for “Unplugging Ovarian Cancer from the Power of Platelets.” Dr. Stone strongly believes in a multidisciplinary team approach to gynecologic cancer care. She seeks to provide women with the most advanced and personalized treatment plans while best preserving quality of life. She enjoys working with community providers so that patients are comforted by receiving care close to home. Dr. Stone is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy. Dr. Stone is board certified in American Board Of Obstetrics And Gynecology.

Brad Cogan is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Cogan is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Peritonitis, Secondary Peritonitis, Lung Nodules, End-Stage Renal Disease (ESRD), and Ureteroscopy.

David Sill is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Sill is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Retroperitoneal Fibrosis, Intussusception in Children, Nonalcoholic Steatohepatitis (NASH), and Visceromegaly.

Takeo Fujii is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Fujii is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and PIK3CA-Related Overgrowth Spectrum. Dr. Fujii is board certified in American Board Of Internal Medicine.

Panayotis Ledakis is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Ledakis is rated as an Advanced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 79 other conditions, according to our data. His clinical expertise encompasses Appendix Cancer, Desmoplastic Small Round Cell Tumor, Anemia, Colorectal Cancer, and Ureteroscopy.

Dana Roque is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Roque is rated as an Advanced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Cervical Cancer, Vaginal Cancer, Bladder Reconstruction, and Hernia Surgery.

Laila Mahmood is a Palliative Medicine provider practicing medicine in Silver Spring, Maryland. She has been practicing medicine for over 18 years. Dr. Mahmood is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Epithelioid Sarcoma, Von Gierke Disease, and Hemoglobinopathy.

Dwight Im is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Im is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Rectocele, Endometrial Cancer, Endometrial Stromal Sarcoma, Hysterectomy, and Oophorectomy.

Giovanna Tosato is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Tosato is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Kaposi Sarcoma, Lymphoid Hyperplasia, Castleman Disease, and Multicentric Castleman Disease (MCD).

Yong Tang is an Oncologist practicing medicine in Hagerstown, Maryland. Dr. Tang is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anemia, Pulmonary Embolism, and Iron Deficiency Anemia.

Jean Anderson is an Obstetrics and Gynecologist practicing medicine in Baltimore, Maryland. Dr. Anderson is rated as an Experienced provider by MediFind in the treatment of Trophoblastic Tumor Placental Site. Her clinical expertise encompasses Cervical Cancer, Gestational Trophoblastic Disease, Human Papillomavirus Infection, and Cervical Dysplasia.